IQV · Iqvia Holdings Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-02 | Berkshire James G. |
See Remarks |
Other↓
|
Common Stock
|
2,713 |
| 2026-09-02 | Berkshire James G. |
See Remarks |
Convert↓
|
Stock Appreciation Right
|
5,381 |
| 2026-09-02 | Berkshire James G. |
See Remarks |
Convert↑
|
Common Stock
|
5,381 |
| 2026-09-02 | Berkshire James G. |
See Remarks |
Sell↓
|
Common Stock
|
2,668 |
| 2026-08-03 | STAUB W RICHARD |
See Remarks |
Sell↓
|
Common Stock
|
5,500 |
| 2026-07-31 | Patel Bhavik |
See Remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.22 to $235.29, inclusive. |
Common Stock
|
1,855 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Other↓
Filing footnotes — Common Stock (Direct)
Represents the exercise of stock appreciation rights expiring on February 2, 2027. |
Common Stock
|
47,858 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the exercise of stock appreciation rights expiring on February 2, 2027. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive. |
Common Stock
|
53,191 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents the exercise of stock appreciation rights expiring on February 2, 2027. |
Common Stock
|
156,206 |
| 2026-07-29 | Cherofsky Keriann |
See Remarks |
Sell↓
|
Common Stock
|
558 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the exercise of stock appreciation rights expiring on February 2, 2027. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive. |
Common Stock
|
4,465 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the exercise of stock appreciation rights expiring on February 2, 2027. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive. |
Common Stock
|
4,584 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the exercise of stock appreciation rights expiring on February 2, 2027. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive. |
Common Stock
|
44,039 |
| 2026-07-29 | Sherbet Eric |
See Remarks |
Sell↓
|
Common Stock
|
5,000 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Other↓
Filing footnotes — Common Stock (Direct)
Represents the exercise of stock appreciation rights expiring on February 2, 2027. |
Common Stock
|
2,069 |
| 2026-07-29 | BOUSBIB ARI |
Director |
Convert↓
|
Stock Appreciation Right
|
156,206 |
| 2026-07-14 | GOGGINS COLLEEN A |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
183 |
| 2026-07-14 | Wims Morris Leslie |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
148 |
| 2026-07-14 | DANHAKL JOHN G |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
160 |
| 2026-07-14 | Fasano Jim |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
195 |
| 2026-05-07 | Wims Morris Leslie |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
171 |
| 2026-05-07 | Fasano Jim |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
228 |
| 2026-05-07 | DANHAKL JOHN G |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
185 |
| 2026-05-07 | GOGGINS COLLEEN A |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
214 |
| 2026-04-23 | DANHAKL JOHN G |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Shares held in the Danhakl Revocable Family Trust. |
Common Stock
(I)
|
1,571 |
| 2026-04-23 | LEONARD JOHN M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. |
Common Stock
|
1,571 |
| 2026-04-23 | GOGGINS COLLEEN A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. |
Common Stock
|
1,571 |
| 2026-04-23 | Kaelin William G Jr |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
1,571 |
| 2026-04-23 | Burt Carol |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Shares held in Carol Burt Hilliard Revocable Trust. |
Common Stock
(I)
|
1,571 |
| 2026-04-23 | Fasano Jim |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
1,571 |
| 2026-04-23 | Wims Morris Leslie |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
1,571 |
| 2026-04-23 | Stamps Sheila A |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
1,571 |
| 2026-02-13 | Fedock Michael J. |
See Remarks |
Tax↓
|
Common Stock
|
123 |
| 2026-02-13 | Haas Bernd |
See Remarks |
Tax↓
|
Common Stock
|
20 |
| 2026-02-09 | STAUB W RICHARD |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
26,088 |
| 2026-02-09 | Cherofsky Keriann |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
2,795 |
| 2026-02-09 | BOUSBIB ARI |
Director |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
78,264 |
| 2026-02-09 | Berkshire James G. |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
11,180 |
| 2026-02-09 | DANHAKL JOHN G |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
172 |
| 2026-02-09 | Fasano Jim |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
211 |
| 2026-02-09 | GOGGINS COLLEEN A |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
198 |
| 2026-02-09 | Patel Bhavik |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
11,180 |
| 2026-02-09 | Fedock Michael J. |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
18,634 |
| 2026-02-09 | Wims Morris Leslie |
Director |
Award↑
Filing footnotes — Deferred Shares (Direct)
Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |
Deferred Shares
|
159 |
| 2026-02-09 | Grenfell Alistair |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
26,088 |
| 2026-02-09 | Sherbet Eric |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
12,112 |
| 2026-02-09 | Haas Bernd |
See Remarks |
Award↑
Filing footnotes — Stock Appreciation Right (Direct)
This stock appreciation right vests in three annual installments beginning on February 9, 2027. |
Stock Appreciation Right
|
11,180 |
| 2026-02-08 | Grenfell Alistair |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. |
Common Stock
|
11,795 |
| 2026-02-08 | Haas Bernd |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13 and May 10, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. |
Common Stock
|
8,265 |
| 2026-02-08 | STAUB W RICHARD |
See Remarks |
Award↑
Filing footnotes — Common Stock (Direct)
Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026. |
Common Stock
|
2,722 |